Deep Vein Thrombosis (DVT) Prevention and Treatment Product (QJ-B100)

Deep Vein Thrombosis (DVT) Prevention and Treatment Product (QJ-B100)

$1,790.00
Skip to product information
Deep Vein Thrombosis (DVT) Prevention and Treatment Product (QJ-B100)

Deep Vein Thrombosis (DVT) Prevention and Treatment Product (QJ-B100)

$1,790.00

Deep Vein Thrombosis (DVT) Prevention and Treatment Product(QJ-B100)

Technical Specifications

  1. Screen and Operation

    • 5-inch capacitive touchscreen

    • Based on the T5L1 chip

    • DGUS II operating system

    • Resolution: 480 × 854

    • 16.7 million colors

  2. Treatment Modes

    • Manual Treatment

    • Standard Treatment

  3. Treatment Pressure

    • Maximum treatment pressure: 300 mmHg

    • Minimum treatment pressure: 0 mmHg

    • Pressure adjustment accuracy: 1 mmHg

    • Relevant parameter documentation shall be provided as required by the applicable national regulatory authority.

  4. Treatment Functions

    • Supports both plantar foot pressure cuffs and calf pressure cuffs for treatment.

  5. Device Indication Functions

    • During operation, the screen displays treatment time and pressure.

    • The deviation between the displayed pressure and the actual measured pressure shall not exceed ±5 mmHg.

    • Overpressure warning

    • Underpressure warning

    • Fault warning

    • Dynamic treatment-site indication: the treatment site currently being treated flashes on the screen.

  6. Overpressure Protection

    • The device incorporates dual overpressure protection through both software and hardware safeguards.

    • In the event of overpressure, the device provides an overpressure warning and automatically releases the air pressure inside the chambers.

    • Under a single-fault condition, the system is designed to release the maximum pressure in the chambers and connecting tubing.

    • The pressure delivered to the limb shall not exceed 120% of the maximum treatment pressure for more than 1 second.

    • Relevant parameter documentation shall be provided as required by the applicable national regulatory authority.

  7. Function Control

    • The device is equipped with an output stop switch, allowing the treatment procedure to be interrupted at any time.

  8. Fault Self-Inspection

    • The device is equipped with a fault self-inspection function.

  9. Pulse Width and Refill Time

    • Adjustable pulse width: Levels 1–5

    • Adjustable refill time: 20–70 seconds

  10. Pressure Release Measures

The device provides pressure-release measures under the following conditions:

a. Manual pressure release:
The patient pressure can be manually released under various operating conditions. Disconnecting the ventilation tubing is sufficient to release the pressure.

b. Completion of treatment:
Automatic pressure release occurs when the preset treatment time is reached and the treatment program is completed.

c. Power interruption:
Automatic pressure release occurs in the event of sudden loss of power.

d. Device fault:
Automatic pressure release occurs when a fault is detected and a fault warning is triggered.

e. Temporary treatment interruption:
Automatic pressure release occurs when the treatment program is temporarily interrupted.

In all of the above situations, pressure release shall be completed with a single action. The time required for the patient pressure to decrease from the maximum pressure to 2 kPa shall not exceed 10 seconds.

  1. Installation and Mounting

  • Suitable for bedside use.

  • Can also be mounted on a dedicated medical trolley.

  1. Safety and Pressure Resistance

  • The chambers and connecting tubing shall withstand a pressure of 450 mmHg for 1 minute without rupture or permanent (plastic) deformation.

  • Connections shall remain secure without loosening or visible deformation.

  • The chambers and connecting tubing shall withstand sudden external forces without localized bulging or rupture.

You may also like